News

Blueberry Therapeutics secures further investment

NPIF – Maven Equity Finance, managed by Maven Capital Partners (“Maven”) and part of the Northern Powerhouse Investment Fund (“NPIF”) has invested £750,000 in Blueberry Therapeutics Limited (“Blueberry&rdq...

Infex Therapeutics partners with Alderley Analytical

Alderley Park, Cheshire Infex Therapeutics has today announced a deal with Alderley Analytical, to support PK and ADA analysis of Infex’s RESP-X program. RESP-X is an anti-virulence therapy in-licensed from Japanese pharma company Shio...

INFEX Therapeutics appoints Lonza to manufacture new lung infection drug

Alderley Park, Cheshire - Infex Therapeutics has awarded a £1m contract to Lonza to help progress its RESP-X program, a novel therapy which targets serious recurrent respiratory infections in patients with damaged lung functions. RESP...

Digital health start-up Clin-e-cal launches free app to help improve inhaler technique and reduce asthma attacks

Manchester-based digital health start-up Clin-e-cal has launched a free app to help people with respiratory diseases to monitor and improve their inhaler technique. The Clip-Tone Buddy app is the first digital solution which can provide real time...

British Pharmaceutical Company Maxwellia Secures Government Future Fund investment to Spearhead Shift in Self-Care

Maxwellia, a pioneering British business that is poised to transform the UK’s self-care market through its specialist model of making more medicines available to buy from UK pharmacies has received a £500k investment from the UK Govern...

From our portfolio

metaLinear

Biotechnology

viewview our portfolio

Our Team

Nick Wright

CEO

view complete team

Contact us

Tel: 01625 344300

email